ZHEJIANG SHENGDA BIO-PHARM CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.91 CNY | +9.98% |
|
+17.95% | -25.12% |
| Sales 2022 | 738M 102M 8.49B | Sales 2023 | 727M 100M 8.37B | Capitalization | 2.49B 343M 28.61B |
|---|---|---|---|---|---|
| Net income 2022 | 31M 4.28M 357M | Net income 2023 | -54M -7.45M -621M | EV / Sales 2022 | 2.52 x |
| Net cash position 2022 | 288M 39.76M 3.31B | Net cash position 2023 | 88.29M 12.19M 1.02B | EV / Sales 2023 | 3.3 x |
| P/E ratio 2022 |
69.7
x | P/E ratio 2023 |
-45.5
x | Employees | 1,152 |
| Yield 2022 |
0.48% | Yield 2023 |
-
| Free-Float | 42.01% |
More Fundamentals
* Assessed data
More news
| 1 day | +9.98% | ||
| 1 week | +17.95% | ||
| Current month | -13.14% | ||
| 1 month | -29.66% | ||
| 3 months | -17.72% | ||
| 6 months | -18.88% | ||
| Current year | -25.12% |
1 week
9.03
10.91
1 month
8.7012.92
Current year
7.0115.51
1 year
7.0116.24
3 years
7.0120.00
5 years
7.0143.91
10 years
7.0143.91
| Managers | Title | Age | Since |
|---|---|---|---|
Bin Zhou
CEO | Chief Executive Officer | 58 | 13/13/13 |
Xiang Xiao Xu
DFI | Director of Finance/CFO | 44 | 27/22/27 |
Jing Zhu
BRD | Director/Board Member | 38 | 01/12/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bu Fei Chen
BRD | Director/Board Member | 64 | 24/13/24 |
Xi Qin Chen
BRD | Director/Board Member | 59 | 18/19/18 |
Yong Quan Li
BRD | Director/Board Member | 62 | 17/21/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 10.91 | +9.98% | 9,025,532 |
| 25/24/25 | 9.92 | +0.92% | 2,877,200 |
| 24/24/24 | 9.83 | +3.15% | 2,799,848 |
| 23/24/23 | 9.53 | +1.93% | 3,175,948 |
| 22/24/22 | 9.35 | +1.08% | 3,445,460 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
ZHEJIANG SHENGDA BIO-PHARM CO., LTD. is a China-based company principally engaged in the research, development, production and sales of vitamins and biological preservatives. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The Company distributes its products in domestic market and to overseas markets.
Sector
Food Processing
Calendar
10/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -25.12% | 255M | |
| +8.20% | 7.78B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- 603079 Stock
